Position in CDXS
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$11,641
-$2,214 QoQ
Shares Held
7,142
-16.0% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CDXS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Legal & General Group Plc holds $2,996,125,878 across 242 Biotechnology names. CDXS ranks #213 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,955,764 | $873,326,855 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
732,054 | $565,614,201 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
934,881 | $309,324,075 | |
| 4 | RPRX |
Royalty Pharma plc
|
3,362,872 | $161,316,968 | |
| 5 | INCY |
Incyte Corp
|
1,543,188 | $145,244,853 | |
| 6 | INSM |
INSMED Inc
|
787,079 | $128,703,157 | |
| 7 | ARGX |
Argenx SE
|
150,850 | $110,158,211 | |
| 8 | MRNA |
Moderna, Inc.
|
750,841 | $38,142,721 |
All Filings in CDXS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,641 | 7,142 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $13,855 | 8,500 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $20,740 | 8,500 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $20,740 | 8,500 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $19,768 | 7,349 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $35,054 | 7,349 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $18,978 | 6,162 | Shares | Defined | 2025-02-28 | |
| 2024-06-30 | $19,102 | 6,162 | Shares | Defined | 2025-05-29 | |
| 2024-03-31 | $21,505 | 6,162 | Shares | Defined | 2025-05-29 | |
| 2023-12-31 | $18,794 | 6,162 | Shares | Defined | 2025-05-29 | |
| 2023-09-30 | $13,796 | 7,300 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,500,575 | 535,920 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,299,218 | 313,821 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,345,350 | 288,702 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,477,493 | 243,811 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,847,611 | 176,636 | Shares | Defined | 2022-08-22 | |
| 2022-03-31 | $2,306,635 | 111,864 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,835,907 | 90,691 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,588,558 | 111,288 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,762,525 | 121,912 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $2,928,591 | 127,942 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,475,009 | 67,568 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $633,899 | 53,995 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $477,511 | 41,887 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $246,055 | 22,048 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||